In addition to treating diabetes, semaglutide can now be prescribed for weight management for those with obesity or who are overweight. The SELECT study showed in November 2023 that semaglutide delivers a 20 percent reduction in major obesity-related adverse cardiovascular events, such as heart attacks or strokes.